Kymera Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 34.4M | 2.9M | 2.8M | 11.5M | 22.1M | 7.4M | 3.7M | 25.6M |
| Cost of Goods Sold | 0 | -76.2M | 74.1M | 2.1M | 0 | 0 | 0 | 0 |
| Gross Profit | 34.4M | 79.0M | -71.3M | 9.4M | 22.1M | 7.4M | 3.7M | 25.6M |
| R&D Expenses | 98.2M | 83.9M | 74.1M | 78.4M | 80.3M | 71.8M | 60.4M | 59.2M |
| Operating Expenses | 118.5M | 176.9M | 21.2M | 93.9M | 96.5M | 88.1M | 75.9M | 76.6M |
| Operating Income | -84.2M | -97.9M | -92.5M | -84.6M | -74.4M | -80.8M | -72.1M | -50.9M |
| Other Income / Gains | 14.9M | 10.6M | 10.3M | 7.9M | 8.8M | 10.0M | 9.6M | 8.9M |
| Net Income | -69.2M | -87.0M | -82.2M | -76.6M | -65.6M | -70.8M | -62.5M | -42.1M |
| EPS (Diluted) | -0.71 | -0.98 | -0.94 | -0.95 | -0.82 | -0.88 | -0.82 | -0.58 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 1.00 | 27.636 | -25.807 | 0.818 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 20.4M | 16.9M | 17.3M | 17.6M | 16.3M | 16.3M | 15.5M | 17.4M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 20.4M | 16.9M | 17.3M | 17.6M | 16.3M | 16.3M | 15.5M | 17.4M |
| Other Expenses | 0 | 76.1M | -70.2M | -2.1M | 0 | 0 | 0 | 0 |
| Cost And Expenses | 118.5M | 100.8M | 95.3M | 96.0M | 96.5M | 88.1M | 75.9M | 76.6M |
| Interest Income | 15.0M | 10.7M | 10.3M | 8.1M | 8.9M | 10.1M | 9.7M | 8.9M |
| Interest Expense | 61K | 69K | 0 | 108K | 72K | 59K | 60K | 61K |
| Depreciation And Amortization | 2.0M | 2.0M | 2.8M | 2.1M | 2.0M | 2.0M | 2.0M | 1.9M |
| Ebitda | -67.2M | -85.2M | -79.3M | -74.4M | -63.5M | -68.7M | -60.4M | -40.1M |
| Ebitdaratio | -1.954 | -29.773 | -28.70 | -6.485 | -2.872 | -9.292 | -16.156 | -1.562 |
| Operating Income Ratio | -2.449 | -34.229 | -33.474 | -7.368 | -3.368 | -10.922 | -19.279 | -1.985 |
| Income Before Tax | -69.2M | -87.3M | -82.2M | -76.6M | -65.6M | -70.8M | -62.5M | -42.1M |
| Income Before Tax Ratio | -2.015 | -30.508 | -29.73 | -6.676 | -2.967 | -9.569 | -16.703 | -1.64 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -2.015 | -30.43 | -29.73 | -6.676 | -2.967 | -9.569 | -16.703 | -1.64 |
| Epsdiluted | -0.71 | -0.98 | -0.94 | -0.95 | -0.82 | -0.88 | -0.82 | -0.58 |
| Weighted Average Shs Out | 97.5M | 84.4M | 87.3M | 80.4M | 80.1M | 80.0M | 76.1M | 73.1M |
| Weighted Average Shs Out Dil | 97.5M | 84.4M | 87.3M | 80.4M | 80.1M | 80.0M | 76.1M | 73.1M |